Latest news in cooperation with Nordic Life Science

Disappointing trial results from Modus Therapeutics

16 May 2019 | 10:16 am
Disappointing trial results from Modus Therapeutics
The company announces initial results from its Phase II, randomized, double-blind, placebo-controlled study with sevuparin for the management of acute vaso-occlusive crisis (VOC) in patients with sickle cell disease. Data from the study failed to show a meaningful benefit in the total study population, however, the data suggests that sevuparin, at the administered doses, is […]
Latest news in cooperation with Nordic Life Science

Column: Bridge over troubled waters …

15 May 2019 | 4:41 pm
Oresund bridge
Recently, my organization was given the neat task to identify what needs to be done to increase the attractiveness and visibility of the Swedish Life Science sector. Consequently, I spent the first couple of months this year diving into the topic. A core theme being access to finance and how this sector can attract more […]
Latest news in cooperation with Nordic Life Science

Dignitana efforts prompt landmark legislation

14 May 2019 | 8:59 am
DigniCap
The company announces that HB3984, the bill providing coverage for scalp cooling that the company initiated in February with Texas State legislators, was passed in the Texas House of Representatives on Friday. The Bill now moves to the Senate where it will be introduced by Sen. Angela Paxton. Once passed in the Senate, the Bill […]
Latest news in cooperation with Nordic Life Science

Bayer’s new office at Karolinska Institutet is inaugurated

14 May 2019 | 8:51 am
Bayer office Sweden
The inauguration was celebrated with a half-day event in Aula Medica focusing on science and collaboration. “Both Bayer and Karolinska Institutet welcomes collaboration between academia, healthcare and society – it is necessary to collaborate to meet global challenges – we are all in this together,” said Miriam Holstein, CEO of Bayer Nordics when she started […]
Latest news in cooperation with Nordic Life Science

TATAA signs distribution agreement with SensID

14 May 2019 | 8:37 am
handshake
In the agreement, SensID gives TATAA full access to its growing product portfolio for molecular diagnostics and TATAA will represent SensID in Sweden, Denmark, Norway, Finland, Czech and Slovak Republics. “With its strong focus on reference materials for molecular diagnostics, SensID is a perfect solution provider for our services. The SenseID products are also most attractive to our […]
Latest news in cooperation with Nordic Life Science

LEO Pharma strengthens its global development team

13 May 2019 | 11:47 am
Global market
The company has appointed Beth-Anne Lang as Vice President and Head of Global Regulatory Affairs and Christine Garrett as Vice President and Head of Global Project Management. Both will join LEO Pharma on May 13. Based in New Jersey Beth-Anne Lang and Christine Garrett will be based in Madison, New Jersey and be part of […]
Latest news in cooperation with Nordic Life Science

New Senior Vice President Operations at Bactiguard

13 May 2019 | 11:16 am
Daniel Lund
Daniel Lund with many years’ experience in quality, production and supply chain management from the pharmaceutical industry, including AstraZeneca and Pfizer, has been recruited to a new role as Senior Vice President (SVP) Operations. At the same time, Jonas Östregård assumes responsibility for Marketing. Both Daniel and Jonas are members of the management team and […]
Latest news in cooperation with Nordic Life Science

Sana Alajmovic hits GEN’s 2019 Top 10 Under 40

13 May 2019 | 8:48 am
Sana Alajmovic
The international life sciences journal Genetic Engineering News (GEN) has placed Sana Alajmovic, CEO of Sigrid Therapeutics, on its Top 10 Under 40 of 2019, a list of rising stars making their mark in business and academia. The list casts its net internationally to identify emerging leaders among life sciences professionals working in a university, a […]
Latest news in cooperation with Nordic Life Science

Umeå researchers have found a new strategy for tuberculosis treatment

13 May 2019 | 8:33 am
Tuberculosis
Scientists at Washington University School of Medicine and Umeå University have found a molecular compound that prevents and even reverses resistance to the most widely used antibiotic for treating tuberculosis – isoniazid. The research team have discovered a molecule that in conjunction with isoniazid could potentially restore the antibiotic’s effectiveness in people with drug-resistant tuberculosis, […]
Latest news in cooperation with Nordic Life Science

Nexstim enters depression therapy market in Sweden

13 May 2019 | 8:11 am
Nexstim
Nexstim’s business partner PO Medica AB has sold two Navigated Brain Therapy (NBT) systems to two different hospitals Sweden. Both hospitals will be the first in Sweden to have the NBT systems and it will be their first time using navigated Transcranial Magnetic Stimulation (TMS) for the treatment of MDD. The systems will be used for the […]
Login